Muir et al. [32] (low risk) discovered in patients with acute ischemic stroke that the use of allopurinol (300 mg/100 mg) can reduce the increase in intercellular adhesion molecule-1 levels following stroke compared with the placebo (between-group difference: 0.012) [32]. This evidence concerns the gene ICAM1 and stroke disorder.